secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harvard Apparatus Regenerative Technology, Inc. (HRGN)
CIK:        0001563665
Form:       8-K
Filed at:   2022-08-02T23:59:59+00:00
Accession:  0001558370-22-011661
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Biostage shareholders approve reverse stock split ratio of 1-for-1.25 to 1-for-5
--------------------------------------------------------------------------------

- Proposal to amend charter to effect reverse stock split approved with 7,072,052 votes for, 196,116 against, 742 abstained.
- Board retains discretion to choose final ratio between 1:1.25 and 1:5 and to set timing within one year.
- Special meeting held July 28, 2022; result filed August 2, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563665/000155837022011661/0001558370-22-011661-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563665/000155837022011661/tmb-20220728x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-011661

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer